Financial Perspectives Inc trimmed its position in shares of Shopify Inc. (NYSE:SHOP – Free Report) (TSE:SHOP) by 15.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,051 shares of the software maker’s stock after selling 2,720 shares during the quarter. Financial Perspectives Inc’s […]
Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Golden State Equity Partners grew its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 134.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,493 shares of the biopharmaceutical company’s stock after purchasing an additional 14,607 shares during the quarter. Golden […]
Truist Financial Corp decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 17.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,303,487 shares of the biopharmaceutical company’s stock after selling 691,277 shares during the quarter. Truist Financial Corp’s holdings in […]
Nadler Financial Group Inc. lifted its position in shares of Visa Inc. (NYSE:V – Free Report) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,900 shares of the credit-card processor’s stock after buying an additional 44 shares during […]
John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […]
Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]
Stack Financial Management Inc decreased its position in Waste Management, Inc. (NYSE:WM – Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 150,265 shares of the business services provider’s stock after selling 2,984 shares during the quarter. Waste Management comprises about […]
Delta Financial Advisors LLC decreased its holdings in shares of The PNC Financial Services Group, Inc. (NYSE:PNC – Free Report) by 3.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,011 shares of the financial services provider’s stock after selling 308 […]
Investors Asset Management of Georgia Inc. GA ADV grew its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,890 shares of the biopharmaceutical company’s stock after purchasing an additional […]
Consolidated Planning Corp lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 36.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 9,782 shares of the biopharmaceutical company’s stock after selling 5,645 shares during the period. Consolidated Planning Corp’s holdings in Pfizer were worth $282,000 as of its most recent filing with the […]
Private Wealth Partners LLC lessened its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 425,358 shares of the biopharmaceutical company’s stock after selling 43,646 shares during the quarter. Pfizer comprises 1.0% of Private Wealth […]